Cargando…

Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide

Although immune checkpoint inhibitors (ICI) have revolutionized cancer management, patient response can be heterogeneous, and the development of ICI resistance is increasingly reported. Novel treatment strategies are necessary not only to expand the use of ICI to previously unresponsive tumor types...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Aguiar Ferreira, Carolina, Heidari, Pedram, Ataeinia, Bahar, Sinevici, Nicoleta, Granito, Alyssa, Kumar, Hritik Mahajan, Wehrenberg-Klee, Eric, Mahmood, Umar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325142/ https://www.ncbi.nlm.nih.gov/pubmed/35890355 http://dx.doi.org/10.3390/pharmaceutics14071460

Ejemplares similares

HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance
por: Sinevici, Nicoleta, et al.
Publicado: (2020)

Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response
por: LaSalle, Thomas, et al.
Publicado: (2020)

Radiolabeled theranostics: magnetic and gold nanoparticles
por: Same, Saeideh, et al.
Publicado: (2016)

Radiolabelled Aptamers for Theranostic Treatment of Cancer
por: Khalid, Umair, et al.
Publicado: (2018)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics
por: Gilpin, Ian Moore F., et al.
Publicado: (2021)

Production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair
por: McNeil, Brooke L., et al.
Publicado: (2021)

Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics
por: Velikyan, Irina, et al.
Publicado: (2020)

Covalent core-radiolabeling of polymeric micelles with (125)I/(211)At for theranostic radiotherapy
por: Sporer, Emanuel, et al.
Publicado: (2022)

Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies
por: Hrynchak, Ivanna, et al.
Publicado: (2021)

Radiolabeled albumin through S(N)Ar of cysteines as a potential pretargeting theranostic agent
por: Fischer, Niklas H., et al.
Publicado: (2022)

Potential Production of Theranostic Boron Nitride Nanotubes ((64)Cu-BNNTs) Radiolabeled by Neutron Capture
por: Silva, Wellington Marcos, et al.
Publicado: (2021)

Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation
por: Tosato, Marianna, et al.
Publicado: (2022)

Optimized production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair for nuclear medicine
por: McNeil, Brooke L., et al.
Publicado: (2023)

Radiolabeled F(ab′)(2)-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models
por: Bellaye, P.-S., et al.
Publicado: (2018)

Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy
por: Reissig, Falco, et al.
Publicado: (2020)

Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
por: Vatsa, Rakhee, et al.
Publicado: (2020)

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with (68)Ga and (177)Lu as Potential Theranostic Agents
por: Salvanou, Evangelia-Alexandra, et al.
Publicado: (2022)

Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes
por: Goggi, J. L., et al.
Publicado: (2020)

Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
por: Goggi, Julian L., et al.
Publicado: (2021)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with (68)Ga and (177)Lu as Potential Theranostic Agent for Colon Cancer
por: Leonte, Radu Anton, et al.
Publicado: (2021)

Humanization, Radiolabeling and Biodistribution Studies of an IgG(1)-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications
por: Strand, Joanna, et al.
Publicado: (2021)

Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma
por: Ma, Yuxiang, et al.
Publicado: (2021)

Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
por: Goggi, Julian L, et al.
Publicado: (2021)

Hydroxyapatite and Titanium Dioxide Nanoparticles: Radiolabelling and In Vitro Stability of Prospective Theranostic Nanocarriers for (223)Ra and (99m)Tc
por: Suchánková, Petra, et al.
Publicado: (2020)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
por: Ng, Thomas S. C., et al.
Publicado: (2021)

(68)Ga and (188)Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies
por: Verger, Elise, et al.
Publicado: (2016)

Granzymes—Their Role in Colorectal Cancer
por: Pączek, Sara, et al.
Publicado: (2022)

The double-balloon technique: a safe and effective adjunctive technique in patients undergoing arterial therapy for hepatic malignancies with vascular supply not amenable to selective administration
por: Tanaka, Mari, et al.
Publicado: (2023)

Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis
por: Pardo, Julián, et al.
Publicado: (2004)

Brachydactyly mental retardation syndrome with growth hormone deficiency
por: Arefzadeh, Alireza, et al.
Publicado: (2018)

In silico prediction of the granzyme B degradome
por: Wee, Lawrence JK, et al.
Publicado: (2011)

Modulation of Inflammation by Extracellular Granzyme A
por: van Daalen, Kim R., et al.
Publicado: (2020)

Intracellular and Extracellular Roles of Granzyme K
por: Bouwman, Annemieke C., et al.
Publicado: (2021)

Granzyme B in Autoimmune Skin Disease
por: Gleave, Anna, et al.
Publicado: (2023)

Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade
por: Jensen, Christina, et al.
Publicado: (2020)

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes
por: Lu, Chunwan, et al.
Publicado: (2022)

Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation
por: Sutton, Vivien R., et al.
Publicado: (2000)

Identification and annotation of bovine granzyme genes reveals a novel granzyme encoded within the trypsin-like locus
por: Yang, Jie, et al.
Publicado: (2018)

(99m)Tc Radiolabeled HA/TPGS-Based Curcumin-Loaded Nanoparticle for Breast Cancer Synergistic Theranostics: Design, in vitro and in vivo Evaluation
por: Huang, Chong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_scmqii7b0r5sgt1j7ge7qca0e8